» Authors » Marcela Arango-Ospina

Marcela Arango-Ospina

Explore the profile of Marcela Arango-Ospina including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 101
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fellenberg J, Losch S, Arango-Ospina M, Hildenbrand N, Tripel E, Deng L, et al.
Int J Mol Sci . 2024 Oct; 25(19). PMID: 39409160
Despite advances in treatment modalities, bone tumour therapies still face significant challenges. Severe side effects of conventional approaches, such as chemo- and radiation therapy, result in poor survival rates and...
2.
Fiehn L, Kunisch E, Saur M, Arango-Ospina M, Merle C, Hagmann S, et al.
J Biomed Mater Res A . 2024 Apr; 112(10):1740-1759. PMID: 38623001
The 0106-B1-bioactive glass (BG) composition (in wt %: 37.5 SiO, 22.6 CaO, 5.9 NaO, 4.0 PO, 12.0 KO, 5.5 MgO, and 12.5 BO) has demonstrated favorable processing properties and promising...
3.
Westhauser F, Arango-Ospina M, Hupa L, Renkawitz T, Boccaccini A, Kunisch E
Biomed Mater . 2024 Jan; 19(2). PMID: 38266275
Despite their long history of application in orthopedics, the osteogenic and angiogenic properties as well as the cytocompatibility and protein adsorption of the 45S5- (in wt%: 45.0 SiO, 24.5 NaO,...
4.
Rehder F, Arango-Ospina M, Decker S, Saur M, Kunisch E, Moghaddam A, et al.
Biomimetics (Basel) . 2024 Jan; 9(1). PMID: 38248627
An ICIE16-bioactive glass (BG) composition (in mol%: 49.5 SiO, 6.6 NaO, 36.3 CaO, 1.1 PO, and 6.6 KO) has demonstrated excellent in vitro cytocompatibility when cultured with human bone marrow-derived...
5.
Kunisch E, Fiehn L, Saur M, Arango-Ospina M, Merle C, Hagmann S, et al.
Biomater Adv . 2023 Jun; 153:213521. PMID: 37356285
Since the introduction of the 45S5-bioactive glass (BG), numerous new BG compositions have been developed. Compared to the 45S5-BG, 1393-BG shows favorable processing properties due to its low crystallization tendency...
6.
Fellenberg J, Losch S, Marinescu M, Frey B, Lehner B, Arango-Ospina M, et al.
Cancers (Basel) . 2023 Mar; 15(6). PMID: 36980753
Tumor recurrence is a major problem during the treatment of giant cell tumors of bone (GCTB). We recently identified tumor cell-specific cytotoxic effects of bioactive glasses (BGs) toward neoplastic stromal...
7.
Alves A, Arango-Ospina M, Oliveira R, Ferreira I, de Moraes E, Hartmann M, et al.
J Biomed Mater Res B Appl Biomater . 2022 Nov; 111(4):881-894. PMID: 36440654
Bone infection treatment is a significant challenge for the orthopedic field. 3D printing is a promising technology to produce scaffolds with customized architecture, able to stimulate and support bone growth....
8.
Nakiou E, Lazaridou M, Pouroutzidou G, Michopoulou A, Tsamesidis I, Liverani L, et al.
Polymers (Basel) . 2022 Nov; 14(22). PMID: 36433155
Background: Aliphatic polyesters are widely used for biomedical, pharmaceutical and environmental applications due to their high biodegradability and cost-effective production. Recently, star and hyperbranched polyesters based on glycerol and ω-carboxy...
9.
Decker S, Arango-Ospina M, Rehder F, Moghaddam A, Simon R, Merle C, et al.
Sci Rep . 2022 May; 12(1):8510. PMID: 35595847
Due to the pivotal role of angiogenesis in bone regeneration, the angiogenic properties of biomaterials are of high importance since they directly correlate with the biomaterials' osteogenic potential via 'angiogenic-osteogenic...
10.
Fellenberg J, Losch S, Lehner B, Arango-Ospina M, Boccaccini A, Westhauser F
Bioact Mater . 2022 Apr; 15:456-468. PMID: 35386334
Giant cell tumors of bone (GCTB) are associated with massive bone destructions and high recurrence rates. In a previous study, we observed cytotoxic effects of three different compositions of bioactive...